Our technology is revolutionizing radiology. We’d love to work with you to help create better outcomes for patients everywhere.
We created the first FDA-cleared device supports concurrent reading, allowing for faster reading with proven, superior, automatic nodule detection.
Our four FDA-cleared applications are designed to improve reading efficiency and accuracy across the hospital enterprise without requiring additional hardware.
Riverain’s deep learning AI technology is FDA cleared, field tested, and clinically proven to provide real results in radiology.
Riverain Technologies advanced AI imaging software is in use by leading healthcare organizations around the world.
Peer reviews, reference accounts, and independent studies confirm that ClearRead technology is positively impacting the field of radiology.
DAYTON, Ohio – March 13, 2016 – Riverain Technologies’ showcased ClearRead software at the Society of Thoracic Radiology (STR) conference as a Gold level sponsor. Riverain, CEO, Steve Worrell, presented Riverain’s ClearRead CT software as part of the invited speaking session. In a discussion titled “A Novel CT Series for Nodule Detection and Characterization”, Worrell presented how Riverain Technologies ClearRead CT software will change the way that radiologists read Chest CT exams based on a novel vessel suppressed view along with a concurrent reading protocol.
STR is an annual meeting attended by world renowned thoracic radiologists.